mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.004 |
mRNA |
SB-225002 |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.005 |
mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.006 |
mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.006 |
mRNA |
MST-312 |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.007 |
mRNA |
AT7867 |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.007 |
mRNA |
RG-108 |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.007 |
mRNA |
Talazoparib |
GDSC1000 |
pan-cancer |
AAC |
0.088 |
0.007 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.008 |
mRNA |
PF-184 |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.009 |